Alpharma Inc. To Present At The CIBC World Markets 16th Annual Healthcare Conference

FORT LEE, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Alpharma Inc. , a leading global specialty pharmaceutical company, announced today that Alpharma’s senior management will provide an overview of the company’s business at the CIBC World Markets 16th Annual Healthcare Conference on Wednesday, November 9, 2005 at 3:30pm Eastern Standard Time.

This presentation will be audio webcast live and can be accessed on Alpharma’s website at http://www.alpharma.com.

An archived version will be available for 30 days after the live presentation and can be accessed at the same location.

Alpharma press releases are also available at our website: http://www.alpharma.com.

Alpharma Inc. is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. The company recently announced the sale of its global generics business and will be focusing in the future on its high margin specialty pharmaceutical businesses. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world’s leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Alpharma Inc.

CONTACT: Kathleen Makrakis, VP, Investor Relations of Alpharma,+1-201-228-5058, kathleen.makrakis@alpharma.com

MORE ON THIS TOPIC